Page last updated: 2024-08-24

irinotecan and Leukemia, Smoldering

irinotecan has been researched along with Leukemia, Smoldering in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bourhis, JH; Damaj, G; Dreyfus, F; Fenaux, P; Feremans, W; Guerci, A; Ravoet, C; Ribrag, V; Suzan, F; Vantelon, JM	1

Trials

1 trial(s) available for irinotecan and Leukemia, Smoldering

Article	Year
Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts. Leukemia, 2003, Volume: 17, Issue:2 Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents, Phytogenic; Blast Crisis; Bone Marrow; Camptothecin; Disease Progression; Female; Humans; Infusions, Intravenous; Irinotecan; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Survival Analysis; Time Factors	2003

Article

Year

Phase II trial of CPT-11 in myelodysplastic syndromes with excess of marrow blasts.

Leukemia, 2003, Volume: 17, Issue:2

Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Agents, Phytogenic; Blast Crisis; Bone Marrow; Camptothecin; Disease Progression; Female; Humans; Infusions, Intravenous; Irinotecan; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Survival Analysis; Time Factors

2003